BridgeBio Oncology Therapeutics, Inc. (BBOT) valuation · $610.4M cap
BridgeBio Oncology Therapeutics, Inc. (BBOT) $610.4M cap.
| Metric | Value |
|---|---|
| Market cap | $610.4M |
| Revenue | $3.6M |
| P/S | 171.9 |
| P/B | 1.7 |
BBOT valuation FAQ
What is BBOT's market cap?
BridgeBio Oncology Therapeutics, Inc. (BBOT) market cap is $610.4M on the latest cached fundamentals snapshot.
What is BBOT's latest revenue?
Latest cached BridgeBio Oncology Therapeutics, Inc. (BBOT) revenue was $3.6M. Statements: https://lician.com/financials/bbot
What is BBOT's price-to-sales ratio?
BridgeBio Oncology Therapeutics, Inc. (BBOT) price-to-sales (P/S) is 171.9, cached market cap $610.4M divided by revenue $3.6M.
What is BBOT's price-to-book ratio?
BridgeBio Oncology Therapeutics, Inc. (BBOT) price-to-book (P/B) is 1.7 on the latest cached fundamentals snapshot.
How many BBOT valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for BridgeBio Oncology Therapeutics, Inc. (BBOT): Market cap, Revenue, P/S, and P/B.
Where is BBOT valuation listed?
Cached valuation multiples for BridgeBio Oncology Therapeutics, Inc. (BBOT) are listed at https://lician.com/valuation/bbot.
Not investment advice. Cached rows, not a live tape.